The rationale for using hydroxycarbamide in the treatment of sickle cell disease" (Haematologica 2011;96:488-491). Reply.

ABSTRACT:

SUBMITTER: Pollack S 

PROVIDER: S-EPMC3105659 | biostudies-literature | 2011 Jun

REPOSITORIES: biostudies-literature